AnaptysBio, Inc. (ANAB) stock analysis

ANAB · AnaptysBio, Inc.

Latest recorded price: USD 45.61

Sector and industry: Healthcare · Biotechnology

Fiscal 2026 figures: revenue growth 139.1%. The model flags 1 risk signal for this company.

Similar companies in Healthcare